| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |